Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 50 Lung Neoplasms 25 Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasm Metastasis 6 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Mesothelioma, Malignant 3 Melanoma 3 Colonic Neoplasms 3 Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Non-squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Mesothelioma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Adenocarcinoma of Lung 2 Vaccinia 1 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1

Interventions

pembrolizumab 2 tislelizumab 1 sotorasib 1 sacituzumab govitecan 1 fludarabine 1 SYS6006 COVID-19 vaccine 1 Pemetrexed 1 Panitumumab 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Drug Therapy 1 Cetuximab 1 Carboplatin 1 Antiemetics 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors × Pemetrexed × 30 days × Clear all

NCT05067283 2026-05-26

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡